Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01708382 · ClinicalTrials.gov registry record · NA
Feasibility Study: Lifting and Tightening of the Elbows
A NA study of Skin Laxity, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT01708382: Completed NA study of Skin Laxity, sponsored by Ulthera.
NCT01708382 is a NA study of Skin Laxity that has completed, run by Ulthera. The registered enrollment target is 21 participants, below the 189-participant average among 10 other Skin Laxity trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01708382, a NA study of Skin Laxity, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
Up to 20 subjects will be treated. Treated subjects will receive one Ulthera® treatment on the elbows. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.
Primary Outcome
Determined by masked assessment analysis of photographs at 90 days post treatment compared to baseline.
Conditions Studied
Interventions
- DEVICE Ulthera System Treatment
Study Locations (1)
New York
- New York Cosmetic, Skin and Laser Surgery Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-02 |
| Phase | NA |
What the finished NCT01708382 record still lists
NCT01708382 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 189-participant average among 10 other Skin Laxity trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Skin Laxity appearing as the primary indexed condition, and to 1 intervention - of which Ulthera System Treatment is the first listed.
NCT01708382 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01708382 about?
NCT01708382 is a clinical study titled "Feasibility Study: Lifting and Tightening of the Elbows". Up to 20 subjects will be treated. Treated subjects will receive one Ulthera® treatment on the elbows. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.
What is the current status of trial NCT01708382?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2011-09. Estimated completion is 2013-02.
What conditions does trial NCT01708382 study?
This clinical trial studies the following conditions: Skin Laxity.
What interventions are being tested in trial NCT01708382?
The interventions under investigation include: Ulthera System Treatment (DEVICE).
Who is sponsoring clinical trial NCT01708382?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01708382 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Laxity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01708382's enrollment target sits among peer trials
21 9th of 10 higher than 2 of 10 other Skin Laxity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Laxity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
RECRUITING · NA
-
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
RECRUITING · NA
-
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
RECRUITING · NA
-
AV-23-001 AVAVA MIRIA Pilot Study
ACTIVE NOT RECRUITING · NA
-
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
ACTIVE NOT RECRUITING · NA
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia